Holen Sie sich die Stockscreener-App
41.16
2.21%
0.89
Schlusskurs vom Vortag:
$40.27
Offen:
$40.12
24-Stunden-Volumen:
625.94K
Relative Volume:
0.83
Marktkapitalisierung:
$3.18B
Einnahmen:
$13.17M
Nettoeinkommen (Verlust:
$-199.06M
KGV:
-15.02
EPS:
-2.74
Netto-Cashflow:
$-156.53M
1W Leistung:
+0.98%
1M Leistung:
-4.37%
6M Leistung:
+35.13%
1J Leistung:
+3.42%
1-Tages-Spanne:
$39.09
$41.50
1-Wochen-Bereich:
$39.09
$42.30
52-Wochen-Spanne:
$26.74
$44.23
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
Firmenname
Xenon Pharmaceuticals Inc
Sektor
Branche
Telefon
(604) 484-3300
Adresse
200 - 3650 GILMORE WAY, BURNABY
Vergleichen Sie XENE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
41.16 | 3.11B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Fortgesetzt | Wells Fargo | Overweight |
| 2025-05-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-10-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-01-04 | Eingeleitet | Citigroup | Buy |
| 2023-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2023-04-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-14 | Eingeleitet | Goldman | Buy |
| 2022-12-12 | Eingeleitet | Cowen | Outperform |
| 2022-11-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-19 | Eingeleitet | Raymond James | Outperform |
| 2022-08-29 | Eingeleitet | BofA Securities | Buy |
| 2022-07-21 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-10-02 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-21 | Eingeleitet | Needham | Buy |
| 2020-06-01 | Fortgesetzt | Jefferies | Buy |
| 2020-03-25 | Eingeleitet | Wedbush | Outperform |
| 2020-01-08 | Eingeleitet | William Blair | Outperform |
| 2019-09-20 | Eingeleitet | Guggenheim | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2017-03-13 | Eingeleitet | Jefferies | Buy |
| 2016-10-21 | Eingeleitet | Stifel | Buy |
| 2016-09-26 | Eingeleitet | Guggenheim | Buy |
| 2016-04-14 | Bestätigt | Jefferies | Buy |
| 2015-10-30 | Fortgesetzt | Jefferies | Buy |
| 2014-12-02 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Xenon Pharmaceuticals Inc Aktie (XENE) Neueste Nachrichten
Is Xenon Pharmaceuticals Inc. stock a dividend growth opportunityQuarterly Profit Report & Daily Profit Focused Screening - newser.com
Envestnet Asset Management Inc. Decreases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - Defense World
How Xenon Pharmaceuticals Inc. stock performs during Fed tightening cyclesQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Why Xenon Pharmaceuticals Inc. stock is recommended by analystsPortfolio Profit Report & Long-Term Growth Plans - newser.com
Why Xenon Pharmaceuticals Inc. stock could outperform in 2025Trend Reversal & AI Enhanced Execution Alerts - newser.com
Short interest data insights for Xenon Pharmaceuticals Inc.Weekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
Can Xenon Pharmaceuticals Inc. stock deliver sustainable ROEInsider Selling & AI Forecasted Stock Moves - newser.com
Technical signs of recovery in Xenon Pharmaceuticals Inc.Weekly Volume Report & Target Return Focused Picks - newser.com
Bank of New York Mellon Corp Raises Stock Position in Xenon Pharmaceuticals Inc. $XENE - Defense World
Xenon Pharmaceuticals (NASDAQ:XENE) Given New $60.00 Price Target at JPMorgan Chase & Co. - Defense World
Using Ichimoku Cloud for Xenon Pharmaceuticals Inc. technicalsSwing Trade & Risk Managed Investment Strategies - newser.com
How strong is Xenon Pharmaceuticals Inc. stock revenue growthWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
Will Xenon Pharmaceuticals Inc. stock continue dividend increasesQuarterly Portfolio Review & Daily Profit Focused Screening - newser.com
Chart overlay techniques for tracking Xenon Pharmaceuticals Inc.2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Why Xenon Pharmaceuticals Inc. stock is trending among retail tradersTreasury Yields & Proven Capital Preservation Tips - newser.com
When is the best time to exit Xenon Pharmaceuticals Inc.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Meme Stocks: How Xenon Pharmaceuticals Inc. stock performs in rising dollar environmentEarnings Miss & High Yield Equity Trading Tips - Fundação Cultural do Pará
Xenon Pharmaceuticals at Stifel 2025: Strategic Expansion and Financial Stability - Investing.com Canada
What MACD and RSI say about Xenon Pharmaceuticals Inc.Weekly Earnings Recap & Daily Risk Controlled Trade Plans - newser.com
Xenon Pharmaceuticals Inc Stock Analysis and ForecastHead and Shoulders Patterns & Access Free Tools and Start Investing - earlytimes.in
What valuation multiples suggest for Xenon Pharmaceuticals Inc. stock2025 Top Decliners & Daily Entry Point Alerts - newser.com
Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):